Back
Evaxion Biotech AS Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
1
EVAX
Evaxion Biotech AS
Last Price:
1.37
Seasonality Move:
-40.11%
Sell
20
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.63
Seasonality Move:
50.57%
Sell
1
Evaxion Biotech AS (EVAX)
is a Sell
Is Evaxion Biotech AS a Buy, Sell or Hold?
- The current Evaxion Biotech AS [EVAX] share price is $1.40. The Score for EVAX is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- EVAX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
20
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.66. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
EVAX Stock Price Chart
What is Evaxion Biotech AS's stock price today?
-
The Evaxion Biotech AS share price today is $1.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVAX is experiencing slight selling pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
EVAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.33 | Sell |
Relative Strength Index (14 RSI): | 23.21 | Sell |
Chaikin Money Flow: | -10444 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.91 - 2.85) | Sell |
Bollinger Bands (100): | (2.42 - 3.24) | Sell |
ADAP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 38.6 | Sell |
Chaikin Money Flow: | -1006052 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.67 - 0.83) | Sell |
Bollinger Bands (100): | (0.81 - 1.21) | Sell |
EVAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.78 | Sell |
20-day SMA: | 2.32 | Sell |
50-day SMA: | 2.65 | Sell |
200-day SMA: | 3.2 | Sell |
8-day EMA: | 1.76 | Sell |
20-day EMA: | 2.15 | Sell |
50-day EMA: | 2.52 | Sell |
200-day EMA: | 3.94 | Sell |
ADAP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.69 | Sell |
20-day SMA: | 0.74 | Sell |
50-day SMA: | 0.86 | Sell |
200-day SMA: | 1.12 | Sell |
8-day EMA: | 0.68 | Sell |
20-day EMA: | 0.74 | Sell |
50-day EMA: | 0.84 | Sell |
200-day EMA: | 1 | Sell |
Evaxion Biotech AS Earnings Growth & EVAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.57 per share, and an increase next year of $0.05 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.
Evaxion Biotech AS Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Adaptimmune Therapeutics PLC Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |